Retraction:

Feng Feng Xu^1,*, Wen Feng Xie^2,*, Guo Qing Zha³, Hong Wu Chen⁴, Liang Deng⁵

¹ Department II of General Surgery, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510700, China
² Department of Intensive Care Unit, The Eastern Hospital of the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510700, China
³ Upper Limb Department of Orthopedics, The Eastern Hospital of the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510700, China
⁴ Department of Emergency, The Eastern Hospital of the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510700, China
⁵ Department of Hepatobiliary Surgery, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen 518107, China
^* These authors have contributed equally to this work

Published: December 31, 2025

Copyright: © 2025 Xu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: Oncotarget has completed its investigation of this paper. Image forensic analysis confirmed that panel J of Figure 2 duplicates panel G of Figure 5, and that panel G of Figure 5 duplicates panel E of Figure 7. In addition, Figure 4C was found to duplicate Figure 5E in reference [1]. The authors agreed that the article should be retracted, although the journal has not received a formal retraction statement from them.

REFERENCES

1. Li N, Cui T, Guo W, Wang D, Mao L. MiR-155-5p accelerates the metastasis of cervical cancer cell via targeting TP53INP1. Onco Targets Ther. 2019; 12:3181–96. https://doi.org/10.2147/OTT.S193097.. [PubMed].

Original article: Oncotarget. 2017; 8:109546–109558. DOI: https://doi.org/10.18632/oncotarget.22726.